Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on March 27th, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on February 25th.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 3/7/2025.
- Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/6/2025.
- Purchased $1,001 - $15,000 in shares of SEA NYSE: SE on 3/5/2025.
- Sold $1,001 - $15,000 in shares of Credo Technology Group NASDAQ: CRDO on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Twilio NYSE: TWLO on 3/4/2025.
- Sold $15,001 - $50,000 in shares of Alibaba Group NYSE: BABA on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Zoom Video Communications NASDAQ: ZM on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Intel NASDAQ: INTC on 3/3/2025.
- Purchased $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 3/3/2025.
UnitedHealth Group Price Performance
NYSE:UNH traded up $8.44 during mid-day trading on Monday, hitting $524.48. The company's stock had a trading volume of 5,024,239 shares, compared to its average volume of 4,764,878. The stock has a fifty day moving average of $508.81 and a 200-day moving average of $543.92. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $479.75 billion, a price-to-earnings ratio of 33.84, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The company's revenue was up 6.8% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is presently 54.19%.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the stock. State Street Corp increased its holdings in UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after buying an additional 319,515 shares in the last quarter. Capital International Investors lifted its stake in UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $6,375,744,000. Finally, Northern Trust Corp boosted its holdings in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares during the last quarter. Institutional investors own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on UNH shares. Cantor Fitzgerald reiterated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a research note on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $629.32.
Get Our Latest Stock Report on UnitedHealth Group
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.33% of the company's stock.
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
